# The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin

> **NCT03895229** · PHASE1 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus
- Pharmacokinetics
- Pharmacodynamics

## Interventions

- **DRUG:** Empagliflozin 10 MG Oral Tablet [Jardiance]

## Key facts

- **NCT ID:** NCT03895229
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2018-10-19
- **Final completion:** 2018-10-26
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03895229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03895229, "The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03895229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*